{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17396", "batch_size": 260, "batch_pos": 209, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses factual language and does not contain high-potency verbs, potent metaphors, superlative negative nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_8624", "batch_size": 260, "batch_pos": 191, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with scale/impact information.", "method": "llm_batch", "batch_id": "batch_3_15316", "batch_size": 260, "batch_pos": 171, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No question is present in the segment.", "method": "llm_batch", "batch_id": "batch_4_5316", "batch_size": 260, "batch_pos": 159, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment states the company is in discussions with the government, which is a factual statement, not an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_18220", "batch_size": 260, "batch_pos": 158, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_12492", "batch_size": 260, "batch_pos": 149, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_14480", "batch_size": 260, "batch_pos": 145, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes discussions on advancing a candidate ('in discussions... on advancing') as a development capability.", "method": "llm_batch", "batch_id": "batch_8_8852", "batch_size": 260, "batch_pos": 92, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
